drugset / Trial / NCT00815373

The Effects of Cosopt® Vs Xalacom® on Ocular Hemodynamics and Intraocular Pressure (IOP) in Primary Open-angle Glaucoma (POAG)

NCT00815373

RandomizedCrossoverQuadruple-blind

Summary

Both Cosopt® and Xalatan® plus Timoptic® will significantly lower IOP, however only Cosopt® will demonstrate positive hemodynamic effects. The clinical significance of this will be investigated by examining the ophthalmic and short posterior ciliary arteries to determine the blood supply to the optic nerve head, the site of damage in glaucoma

Timeline

Start
2008-12
Primary completion
2011-12
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dorzolamide Small molecule Topical
Comparator Latanoprost Small molecule Topical
Comparator Timolol Other / unclassified 0.5 % Topical